EFA Technologies Launches Operations in Brazil with Revolutionary Portable Blood Lab

This expansion comes in the wake of regulatory approval granted last October by Anvisa, the Brazilian health regulatory authority, for EFA's groundbreaking...

April 10, 2024 | Wednesday | News
Hartwig Medical Foundation and Ultima Genomics Partner to Enhance Cancer Genomic Profiling

-Hartwig Medical Foundation, a pioneer in deploying complete genomic profiling to improve oncology outcomes, and Ultima Genomics, a developer of a revoluti...

April 08, 2024 | Monday | News
Nucleai and GoPath Diagnostics Partner to Advance Digital Pathology with AI Integration

Nucleai, a spatial AI biomarker company that deciphers cellular conversations and maps cellular interactions within tissue samples to predict therapeutic o...

April 08, 2024 | Monday | News
Bruker Introduces Novel NMR Capabilities for Structural Biology in Proteins

Bruker Corporation (Nasdaq: BRKR), the leading provider of nuclear magnetic resonance (NMR) spectroscopy solutions, announces the introduction of novel hig...

April 08, 2024 | Monday | News
GE HealthCare Introduces Caption AI for Vscan Air SL Ultrasound System, Enhancing Cardiac Care Accessibility

GE HealthCare (Nasdaq: GEHC) announces a groundbreaking advancement in cardiac care with the launch of Caption AI artificial intelligence (AI)-driven softw...

April 04, 2024 | Thursday | News
UroGen Pharma vs. Teva: Legal Clash Over "Totally Mundane" Cancer Treatment Patents

UroGen Pharma has initiated legal proceedings against pharmaceutical giant Teva over what they're dubbing as "Totally Mundane" Cancer Treatment Patents. Ur...

April 04, 2024 | Thursday | News
Biological Dynamics Expands Adoption of ExoVerita™ Pro Under Early Access Program

“Research has shown that exosomes carry important information about human health, but studying them has proven challenging,” remarked Paul R. B...

April 03, 2024 | Wednesday | News
Agilent Technologies and UC San Diego to Establish Center of Excellence in Cellular Intelligence

Agilent Technologies , a global leader in life sciences, diagnostics, and applied chemical markets, and the University of California San Diego (UC Sa...

April 03, 2024 | Wednesday | News
Genmab to Acquire ProfoundBio for USD 1.8 Billion in Cash

Genmab A/S (Nasdaq: GMAB) and ProfoundBio, Inc. have officially announced a definitive agreement for Genmab's acquisition of ProfoundBio in an all-cash dea...

April 03, 2024 | Wednesday | News
Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders

  Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company specializing in allosteric modulation-based drug development,...

April 03, 2024 | Wednesday | News
Voydeya Approved as Add-On Therapy for Rare PNH Treatment in the US

Voydeya (danicopan) has been granted approval in the United States as an add-on therapy for the treatment of extravascular haemolysis (EVH) in adults diagn...

April 02, 2024 | Tuesday | News
Exact Sciences and Mayo Clinic Report Promising Data on Non-Endoscopic Esophageal Cancer Screening Test

  Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, in collaboration with Mayo Clinic Compr...

March 28, 2024 | Thursday | News
Indegene Bolsters Clinical and Regulatory Writing Expertise with Acquisition of Trilogy Writing & Consulting GmbH

Indegene, a digital-first, life sciences commercialization company, announced the acquisition of Trilogy Writing & Consulting GmbH (Trilogy), a global ...

March 28, 2024 | Thursday | News
Function Oncology and Volastra Therapeutics Form Strategic Partnership to Enhance Precision Cancer Treatment

-Function Oncology, a company transforming the operating system of precision medicine with CRISPR-powered platform technology, today announced an innovativ...

March 27, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in